Ongoing review of medication use and further pharmacoepidemiological and biological analyses are warranted to ensure appropriate use is recommended
Advertisement China GLP-1 drug study suggests slim chance weight stays off after treatment Significant weight returned weeks after stopping drug, say researchers who advise patients to adjust expectations 2-MIN READ2-MIN 1 A Chinese analysis of prescription anti-obesity medications has added to evidence that people who use popular GLP-1 drugs such as Ozempic to shed pounds face the prospect of significant weight rebound once they stop using them challenges similar to those presented by more traditional slimming strategies
We also combined the SSTR antagonists with a DPP-4i to elucidate whether a further improvement in glycemic control could be obtained if the secreted GLP-1 were protected from degradation
5,2 0 0,1 0 L- 900 7,5 15 15 L- , ,
Its pharmaceutical name is bremelanotide
These medications mimic a natural gut hormone to regulate insulin secretion, appetite, and weight
.png)
